诊断学理论与实践 ›› 2022, Vol. 21 ›› Issue (02): 130-132.doi: 10.16150/j.1671-2870.2022.02.004

• 专家建议 • 上一篇    下一篇

新型冠状病毒肺炎疫情下垂体疾病管理专家建议

中华医学会内分泌学分会   

  1. 国家代谢性疾病临床医学研究中心(上海)
  • 收稿日期:2022-05-26 出版日期:2022-05-30 发布日期:2022-04-25
  • 通讯作者: 中华医学会内分泌学分会

Expert suggestion for pituitary disease management during the recent COVID-19 pandemic

Chinese Society of Endocrinology,Chinese Medical Association , et al   

  1. National Metabolic Diseases Clinical Research Center (Shanghai)
  • Received:2022-05-26 Online:2022-05-30 Published:2022-04-25
  • Contact: Chinese Society of Endocrinology,Chinese Medical Association

摘要:

垂体疾病患者常伴有内分泌激素紊乱、肿瘤占位效应和多种合并症,新型冠状病毒(新冠)肺炎疫情期间,其管理难度增加。本专家建议旨在规范垂体疾病原发病的诊治,加强合并症的管理,为新冠疫情期间垂体疾病患者的综合管理,提供必要的参考依据和指导意见。

关键词: 新型冠状病毒, 垂体疾病, 合并疾病

Abstract:

Pituitary disease are often associated with hormonal abnormalities, mass effects and multiple co-morbidities, involving multidisciplinary management and follow-up. The COVID-19 pandemic makes their management much more challenging. Therefore, this expert suggestion aims to standardize the diagnosis and treatment of pituitary disease and strengthen the management of co-morbidities during the current COVID-19 epidemic.

Key words: COVID-19, Pituitary disease, Co-morbidities

中图分类号: